We are not building for the world as it is.
We are building for the world as it will be.
Our sequencing laboratory is based locally in Riyadh with clinical interpretation by our specialist team. One accredited standard, from sample to report.
The global adoption of precision medicine, rare disease diagnostics, and advanced genomic testing continues to grow at an unprecedented pace. As healthcare systems embrace personalized medicine, providers are seeking trusted genomic partners who can deliver high-quality testing, clinically actionable reports, and exceptional scientific support.
To meet these needs, laboratories and healthcare organizations require reliable partners with proven expertise, advanced technologies, rapid turnaround, and a genuine commitment to quality and innovation.
Extensive combined experience across molecular genetics, clinical diagnostics, bioinformatics, and translational research.
CuraGenex is a science-led organization grounded in strong academic and clinical foundations. Our multidisciplinary team spans molecular genetics, clinical diagnostics, bioinformatics, and translational research.
Our team includes nine PhD-level geneticists, providing a strong scientific backbone for clinical interpretation, research, and national capacity building. This depth of expertise enables us to operate confidently at the intersection of healthcare delivery, research translation, and population-scale genomics.
From a single targeted gene to the whole genome — each with a clinical report at the end.
Focus on the protein-coding regions of the genome, where most disease-causing variants are found.
Analyze the entire DNA sequence, including coding and non-coding regions, offering the most complete view of an individual's genetic profile.
Investigate a selected group of genes associated with a specific condition or set of symptoms, offering focused, efficient, and clinically relevant genetic insights.
Molecular assays delivering precise, clinical-grade results targeting specific variants.
An advanced clinical interpretation solution that transforms raw NGS data into clear, actionable reports, bridging complex genomic data and real-world decisions.
From rare and inherited disease to undiagnosed cases and precision medicine — genomics applied where it changes outcomes.
Rare disease affects over 300 million people globally. A timely genetic diagnosis resolves uncertainty and can unlock life-altering treatment.
Beyond guiding treatment, a genetic diagnosis can identify at-risk family members and inform family planning decisions.
Nearly 80% of conditions with no known cause have an underlying genetic basis. Genetic testing is the primary tool for solving them.
Partnering with CuraGenex lets distributors expand their portfolio, strengthen their market position, and participate in the growing genomics sector — without building their own sequencing infrastructure. Our objective is not simply to provide testing, but to help partners build sustainable, profitable genomics businesses.
Backed by international quality standards, advanced technology, and a long-term commitment to partner success, we serve as a reliable strategic partner dedicated to consistent quality, scientific excellence, and sustainable growth.
Tell us about your market and objectives, and we'll show you how a CuraGenex partnership can open new opportunities for growth.